bpc-157 spinal cord injury Novel Therapeutic Effects in Rat Injuries: Recovery of the Definitive and Early Spinal Cord by the Administration of Pentadecapeptide BPC 157 Therapy bpc-157 herniated disc research Stable

Massa SM, Yang T, Xie Y, Shi J, Bilgen M, et al

If taking medication or if you have a medical condition, consult your healthcare professional before use

You may also like Product Description DSIP Peptide | Buy DSIP UK | Research Use Only DSIP Delta Sleep-Inducing Peptide is a naturally occurring amphiphilic nonapeptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu, MW 849 Da) first isolated from rabbit cerebral venous blood in 1977 by the Schoenenberger-Monnier group at the University of Basel, found in both free and bound forms in the hypothalamus, limbic system, pituitary, gut, pancreas, and body fluids, that in pre-clinical and limited clinical research demonstrates a uniquely broad neuromodulatory profile promoting delta-wave slow-wave sleep (SWS), modulating corticotropin and GH release, exerting stress-protective and adaptogenic activity, reducing mitochondrial oxidative stress under hypoxia, demonstrating anticonvulsant and antinociceptive activity, accelerating motor research applications post-stroke, and exhibiting geroprotective and anticarcinogenic properties in long-term murine studies making it one of the most pharmacologically diverse endogenous regulatory neuropeptides in the sleep and stress research literature, despite its receptor remaining formally unidentified

BPC-157 Capsules Pentadecapeptide Research Compound (Oral Format) Compound Name: BPC-157 (Body Protection Compound-157) Classification: Research Peptide Pentadecapeptide Description: BPC-157 is a synthetic pentadecapeptide composed of 15 amino acids and originally derived from a naturally occurring protective protein found within the gastric system